165 - Real-world Abrysvo Vaccine Effectiveness (VE) against Respiratory Syncytial Virus (RSV)-related Severe Acute Respiratory Infection (ARI) Hospitalizations and Emergency Department (ED) Visits—Kaiser Permanente of Southern California (KPSC), November 2023–April 2024

Thursday, October 17, 2024

1:57 PM – 2:09 PM US PT

Location: 403 A

Presenting Author(s)

Sara Y. Tartof, PhD MPH

Epidemiologist/Research Scientist II
Kaiser Permanente Southern California
Pasadena, CA, United States

Slides

Co-Author(s)

Negar Aliabadi, MD, MS

Senior Director
Pfizer
New York, New York, United States
GG

Gabriella Goodwin, MS

Kaiser Permanente, Southern California
Pasadena, California, United States
JS

Jeff Slezak, MS

Research Scientist Biostatistician
Kaiser Permanente Southern California
Pasadena, California, United States
VH

Vennis Hong, MPH

Kaiser Permanente
El Monte, California, United States
Bradley Ackerson, MD (he/him/his)

Co-Investigator
Kaiser Permanente Southern California
Pasadena, California, United States
QL

Qing Liu, M.S.

Pfizer Inc.
Collegeville, Pennsylvania, United States
SS

Sally Shaw, DrPH, MPH

Kaiser Permanente Southern California
Pasadena, California, United States
SW

Sabrina Welsh, MPH

Director, Clinical Scientist
Pfizer, Inc
Collegeville, Pennsylvania, United States
JS

Julie Stern, MPH

Kaiser Permanente Southern California
Pasadena, California, United States
BK

Banshri Kapadia, MS

Kaiser Permanente, Southern California
Pasadena, California, United States
BS

Brigitte Spence, MPH

Kaiser Permanente Southern California
Pasadena, California, United States
JL

Joe Lewnard, PhD

University of California, Berkeley
San Francisco, California, United States
GD

Gregory Davis, MPH, PhD

Kaiser Permanente, Southern California
Pasadena, California, United States
MA

Michael Aragones, MD

Kaiser Permanente Southern California
Pasadena, California, United States
MD

Michael Dutro, PharmD

Pfizer
Santa Fe, New Mexico, United States
EC

Erica Chilson, PharmD

Senior Director, US Medical Affairs
Pfizer
500 Arcola Road, Pennsylvania, United States
EG

Elisa Gonzalez, MS

Pfizer
NY, New York, United States
RH

Robin Hubler, MS

Pfizer
Pfizer Inc.
Collegeville, Pennsylvania, United States
AM

Ashley Miller, MA, CCRP

Director, Clinical Scientist
Pfizer
Collegeville, Pennsylvania, United States
BC

Brandon Chia, n/a

Kaiser Permanente School of Medicine
South Pasadena, California, United States
LJ

Luis Jodar, PhD

Chief Scientific Officer
Pfizer Vaccines
Collegeville, Pennsylvania, United States
BG

Bradford D. Gessner, M.D., M.P.H.

Vice President Global Medical Lead for Respiratory Vaccines
Pfizer Biopharma Group
Collegeville, Pennsylvania, United States
Elizabeth Begier, MD, M.P.H.

Senior Director, Scientific Affairs Lead, RSV Antiviral/Adult Vaccine Program
Pfizer Vaccines
Dublin, Dublin, Ireland

Disclosure(s):

Sara Y. Tartof, PhD MPH: GSK: Funding paid directly to institution; vaccines provided directly to institution; Pfizer Inc.: Funding paid directly to institution; vaccines provided directly to institution

Negar Aliabadi, MD, MS: Pfizer: I am an employee of Pfizer and own stocks in the company

Jeff Slezak, MS: Dynavax Technologies: Grant/Research Support; Pfizer, Inc.: Grant/Research Support

Bradley Ackerson, MD: No financial relationships to disclose

Qing Liu, M.S.: Pfizer Inc: Stocks/Bonds (Public Company)

Sabrina Welsh, MPH: No financial relationships to disclose

Michael Aragones, MD: No financial relationships to disclose

Michael Dutro, PharmD: Pfizer: Employee, Stocks/Bonds (Public Company)

Erica Chilson, PharmD: Pfizer, Inc: Employee, Stocks/Bonds (Public Company)

Elisa Gonzalez, MS: Pfizer: Stocks/Bonds (Private Company)

Ashley Miller, MA, CCRP: Pfizer: Stocks/Bonds (Public Company)

Brandon Chia, n/a: No financial relationships to disclose

Luis Jodar, PhD: No financial relationships to disclose

Bradford D. Gessner, M.D., M.P.H.: Pfizer: Employee, Stocks/Bonds (Public Company)

Elizabeth Begier, MD, M.P.H.: Pfizer: Employee, Stocks/Bonds (Public Company)